JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Evaluation of Nattokinase for Antithrombotic Effect and Pharmacological Efficacy by a Biological Test and Clinical Trial
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : KSBB Journal
  • Volume 26, Issue 5,  2011, pp.393-399
  • Publisher : Korean Society for Biotechnology and Bioengineering
  • DOI : 10.7841/ksbbj.2011.26.5.393
 Title & Authors
Evaluation of Nattokinase for Antithrombotic Effect and Pharmacological Efficacy by a Biological Test and Clinical Trial
Kim, Jae-Bum; Yoo, Chul-Bae; Shin, Hyun-Man; Jung, Joon-Ki; Jang, Hyung-Wook;
  PDF(new window)
 Abstract
Bacillus subtilis natto producing high level of a fibrinolytic enzyme was selected and Ultra Nattokinase was manufactured by fermentation and purification. It was performed the evaluation of the antithrombotic effect of Ultra Nattokinase (20,000 FU/g) with rat blood plasma. The maximum aggregation (inhibition ratio) was 71% (0%), 69% (2.8%), 62% (12.7%), 16% (77.5%) and 9% (87.3%), respectively, in the order of 0, 5, 10, 50 and 100 mg/mL of Ultra Nattokinase solutions. Ultra Nattokinase had antithrombotic effect, which was associated with the suppression of collagen-induced platelet aggregation. Ultra Nattokinase in the topic of the FDP (fibrinogen degradation products) in blood coagulation tests showed a significant increasing trend. And based on the daily record of meal 39 people of ITT (what ?) group consisted with 19 people of NP (what ?) group and 20 people of PN (what ?) group except four people, two people who took vitamin K affecting the experiment and two people who took alcohol, finding to be taken Ultra Nattokinase showed an increase in the FDP value after four weeks. In addition, FDP value of 41 people of ITT group except two people having metabolic syndrome was increased by Ultra Nattokinase.
 Keywords
Bacillus subtilis natto;Ultra Nattokinase;Antithrombotic effect;Pharmacological efficacy;FDP;
 Language
Korean
 Cited by
1.
Bacillus subtilis Natto가 생산하는 Nattokinase의 항혈전 및 피브린 용해능 효능평가,이다령;홍성유;장양수;장형욱;맹창재;유철배;백대헌;

KSBB Journal, 2012. vol.27. 6, pp.375-380 crossref(new window)
1.
The Evaluation of Antithrombotic and Fibrinolytic Activities of Nattokinase from Bacillus subtilis Natto, KSBB Journal, 2012, 27, 6, 375  crossref(new windwow)
 References
1.
Fujita, M., K. Nomura, K. Hong, Y. Ito, A. Asada, and S. Nishimuro (1993) Purification and characterization of a strong fibrinolytic enzyme (nattokinase) in the vegetable cheese natto, a popular soybean fermented food in Japan. Biochem. Biophys. Res. Commun. 197: 1340-1347. crossref(new window)

2.
Al Dieri R., S. Alban, S. Béguin, and H. C. Hemker (2004) Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time. J. Thromb. Haemost. 2: 1395-1401. crossref(new window)

3.
Chang, Y. Y., J. S. Liu, S. L. Lai, H. S. Wu, and M. Y. Lan (2008) Cerebellar hemorrhage provoked by combined use of nattokinase and aspirin in a patient with cerebral microbleeds. Intern. Med. 47: 467-469. crossref(new window)

4.
Omura, K., M. Hitosugi, X. Zhu, M. Ikeda, H. Maeda, and S. Tokudome (2005) A newly derived protein from Bacillus subtilis natto with both antithrombotic and fibrinolytic effects. J. Pharmacol. Sci. 99: 247-251. crossref(new window)

5.
Omura, K., M. Hitosugi, K. Kaketani, X. Zhu, H. Maeda, and S. Tokudome (2004) Fibrinolytic and anti-thrombotic effect of NKCP, the protein layer from Bacillus subtilis natto. Biofactors 22: 185-187. crossref(new window)

6.
Maat, M. P., A. C. de Bart, B. C. Hennis, P. Meijer, A. C. Havelaar, P. G. Mulder, and C. Kluft (1996) Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris. Arterioscler. Thromb. Vasc. Biol. 16: 1156-1162. crossref(new window)

7.
Yamamoto, K., K. Takeshita, T. Kojima, J. Takamatsu, and H. Saito (2005) Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly. Cardiovasc. Res. 66: 276-285. crossref(new window)

8.
Borawski, J. and M. Myśliwiec (2001) Plasma fibrinogen level is an important determinant of prolonged euglobulin clot lysis time in hemodialysis patients. Clin. Appl. Thromb. Hemost. 7: 296-299. crossref(new window)

9.
Kowalski, E., M. Kopec, and Niewiarowski (1959) An evaluation of the euglobulin method for the determination of fibrinolysis. J. Clin. Pathol. 12: 215-218. crossref(new window)

10.
Sumi, H., H. Hamada, K. Nakanishi, and H. Hiratani (1990) Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase. Acta Haematologica 84: 139-143. crossref(new window)

11.
Sasaki, K., S. Moriyama, Y. Tanaka, H. Sumi, N. Toki, and K. C. Robbins (1985) The transport of 125I-labeled human high molecular weight urokinase across the intestinal tract in a dog model with stimulation of synthesis and/or release of plasminogen activators. Blood 66: 69-75.

12.
Hirofumi O., T. Iwakoshi, M. Niwa, Y. Kida, T. Tanaka, R. Kitamura, S. Maezawa, and T. Kobayashi (1996) Coagulation and fibrinolysis study after local thrombolysis of a cerebral artery with urokinase. Neurol. Med. Chir. (Tokyo) 36: 300-304. crossref(new window)

13.
Yoo, C. K., W. S. Seo, C. S. Lee, and S. M. Kang (1998) Purification and characterization of fibrinolytic enzyme excreted by Bacillus subtilis K-54 isolated from Chung Guk Jang. Korean J. Appl. Microbiol. Biotechnol. 26: 507-514.

14.
Astrup, T. and S. Mullertz (1952) The fibrin plate method for estimating fibrinolytic activity. Archs. Biochem. Biophys. 40: 346-347. crossref(new window)

15.
Anson, M. L. (1939) The estimation of pepsin, trypsin, papain and cathepsin with hemoglobin. J. Gen. Physiol. 22: 78-89.

16.
Kimura, S., M. T. Chiang, and H. Fujimoto (1990) Effects of eicosapentanoic acid an soybean protein on plasma cholesterol, blood pressure and platelet aggregation in stroke prone spontaneously hypertensive rats. Monogr. Atheroscler. 16: 26-35.